Related Experiment Video
Updated: Jun 14, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
The Association between Cardiovascular Risk Factors and Lichen Sclerosus: A Systematic Review and Meta-Analysis
Suvijak Untaaveesup1, Piyawat Kantagowit2, Nattawut Leelakanok3
1Phaholpolpayuhasena Hospital, Kanchanaburi 71000, Thailand.
Insights
Lichen sclerosus is linked to type 2 diabetes mellitus. This condition may also correlate with hypertension, dyslipidemia, obesity, and metabolic syndrome, warranting further research.
Area of Science:
- Dermatology
- Cardiology
- Epidemiology
Background:
- Lichen sclerosus is a chronic inflammatory skin condition affecting diverse populations.
- Previous studies suggest links between lichen sclerosus and cardiovascular risk factors, but evidence remains inconclusive.
- Clarifying these associations is crucial for comprehensive patient management.
Purpose of the Study:
- To conduct a meta-analysis synthesizing the current evidence on the association between cardiovascular risk factors and lichen sclerosus.
- To provide a quantitative summary of the relationship between lichen sclerosus and conditions like diabetes, hypertension, and dyslipidemia.
Main Methods:
- Systematic literature search of MEDLINE and EMBASE databases up to May 2024.
- Inclusion of 16 studies (9 case-control, 6 retrospective cohort, 1 cross-sectional) involving 432,457 participants.
- Application of a random-effects model for meta-analysis.
Main Results:
- A significant association was found between lichen sclerosus and type 2 diabetes mellitus (OR: 2.07; 95% CI: 1.21-3.52).
- Trends suggesting increased risk were observed for hypertension (OR: 1.56), dyslipidemia (OR: 1.44), and metabolic syndrome (OR: 1.36), though not statistically significant.
- Obesity showed a wide confidence interval (OR: 5.84; 95% CI: 0.37-92.27), indicating limited statistical power.
Conclusions:
- Lichen sclerosus is significantly associated with type 2 diabetes mellitus.
- Potential correlations exist between lichen sclerosus and hypertension, dyslipidemia, obesity, and metabolic syndrome.
- Further population-based prospective studies are recommended to confirm these associations and their clinical implications.
Abstract:
Background/Objective: Lichen sclerosus is a chronic inflammatory skin disease that affects people of all ages and sexes. Evidence of cardiovascular risk factors in lichen sclerosus has been continuously reported; however, the definitive association remains inconclusive. This meta-analysis aimed to summarize the association between cardiovascular risk factors and lichen sclerosus. Methods: Electronic databases, including MEDLINE and EMBASE, were systematically searched from inception to May 2024 to identify the literature reporting the association between cardiovascular risk factors and lichen sclerosus. A random-effects model was used for the meta-analysis. Results: We included 16 eligible studies: nine case-control studies, six retrospective cohort studies, and one cross-sectional study. A total of 432,457 participants were included. Lichen sclerosus was significantly associated with type 2 diabetes mellitus with an odds ratio of 2.07 (95% CI: 1.21-3.52). Although not statistically significant, a trend of increasing risk in hypertension, dyslipidemia, obesity, and metabolic syndrome was observed among lichen sclerosus patients, with odds ratios of 1.56 (95% CI: 0.90-2.70), 1.44 (95% CI: 0.94-2.23), 5.84 (95% CI: 0.37-92.27), and 1.36 (95% CI: 0.52-3.54), respectively. Conclusions: Lichen sclerosus was associated with diabetes mellitus and potentially correlated with hypertension, dyslipidemia, obesity, and metabolic syndrome. Population-based prospective observational studies are required to further elucidate these findings and assess the impact of these associations.
More Related Videos
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Lipids: Dietary Sources and Requirements

